Annual D&A
$83.90 K
+$68.60 K+448.37%
July 31, 2024
Summary
- As of February 7, 2025, BCTX annual depreciation & amortization is $83.90 thousand, with the most recent change of +$68.60 thousand (+448.37%) on July 31, 2024.
- During the last 3 years, BCTX annual D&A has risen by +$68.60 thousand (+448.37%).
- BCTX annual D&A is now at all-time high.
Performance
BCTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$26.70 K
-$45.70 K-63.12%
October 31, 2024
Summary
- As of February 7, 2025, BCTX quarterly depreciation & amortization is $26.70 thousand, with the most recent change of -$45.70 thousand (-63.12%) on October 31, 2024.
- Over the past year, BCTX quarterly D&A has increased by +$22.90 thousand (+602.63%).
- BCTX quarterly D&A is now -63.12% below its all-time high of $72.40 thousand, reached on July 31, 2024.
Performance
BCTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$106.70 K
+$22.90 K+27.33%
October 31, 2024
Summary
- As of February 7, 2025, BCTX TTM depreciation & amortization is $106.70 thousand, with the most recent change of +$22.90 thousand (+27.33%) on October 31, 2024.
- Over the past year, BCTX TTM D&A has increased by +$91.50 thousand (+601.97%).
- BCTX TTM D&A is now at all-time high.
Performance
BCTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
BCTX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +448.4% | +602.6% | +602.0% |
3 y3 years | +448.4% | +602.6% | +602.0% |
5 y5 years | +448.4% | +602.6% | +602.0% |
BCTX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +448.4% | -63.1% | +602.6% | at high | +602.0% |
5 y | 5-year | at high | +448.4% | -63.1% | +790.0% | at high | +4345.8% |
alltime | all time | at high | >+9999.0% | -63.1% | +381.1% | at high | >+9999.0% |
BriaCell Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Oct 2024 | - | $26.70 K(-63.1%) | $106.70 K(+27.3%) |
Jul 2024 | $83.90 K(+448.4%) | $72.40 K(+1805.3%) | $83.80 K(+451.3%) |
Apr 2024 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Jan 2024 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Oct 2023 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Jul 2023 | $15.30 K(0.0%) | $3800.00(0.0%) | $15.20 K(0.0%) |
Apr 2023 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Jan 2023 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Oct 2022 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Jul 2022 | $15.30 K(0.0%) | $3800.00(0.0%) | $15.20 K(0.0%) |
Apr 2022 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Jan 2022 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Oct 2021 | - | $3800.00(0.0%) | $15.20 K(0.0%) |
Jul 2021 | $15.30 K(0.0%) | $3800.00(0.0%) | $15.20 K(-7.9%) |
Apr 2021 | - | $3800.00(0.0%) | $16.50 K(+5.1%) |
Jan 2021 | - | $3800.00(0.0%) | $15.70 K(+1.9%) |
Oct 2020 | - | $3800.00(-25.5%) | $15.40 K(+1.3%) |
Jul 2020 | $15.30 K(0.0%) | $5100.00(+70.0%) | $15.20 K(+2.0%) |
Apr 2020 | - | $3000.00(-14.3%) | $14.90 K(+520.8%) |
Jan 2020 | - | $3500.00(-2.8%) | $2400.00(0.0%) |
Oct 2019 | - | $3600.00(-25.0%) | $2400.00(-84.2%) |
Jul 2019 | $15.30 K(+17.7%) | $4800.00(-150.5%) | $15.20 K(-35.0%) |
Apr 2019 | - | -$9500.00(-371.4%) | $23.40 K(-28.9%) |
Jan 2019 | - | $3500.00(-78.7%) | $32.90 K(+11.9%) |
Oct 2018 | - | $16.40 K(+26.2%) | $29.40 K(+126.2%) |
Jul 2018 | $13.00 K(+6400.0%) | $13.00 K(>+9900.0%) | $13.00 K(-3350.0%) |
Apr 2018 | - | $0.00(0.0%) | -$400.00(+100.0%) |
Jan 2018 | - | $0.00(0.0%) | -$200.00(<-9900.0%) |
Oct 2017 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Jul 2017 | $200.00 | -$400.00(-300.0%) | $200.00(-80.0%) |
Apr 2017 | - | $200.00(0.0%) | $1000.00(+25.0%) |
Jan 2017 | - | $200.00(0.0%) | $800.00(0.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Oct 2016 | - | $200.00(-50.0%) | $800.00(0.0%) |
Jul 2016 | $900.00(+125.0%) | $400.00(>+9900.0%) | $800.00(+33.3%) |
Apr 2016 | - | $0.00(-100.0%) | $600.00(-25.0%) |
Jan 2016 | - | $200.00(0.0%) | $800.00(+33.3%) |
Oct 2015 | - | $200.00(0.0%) | $600.00(+50.0%) |
Jul 2015 | $400.00(-63.6%) | $200.00(0.0%) | $400.00(-60.0%) |
Apr 2015 | - | $200.00(>+9900.0%) | $1000.00(+11.1%) |
Jan 2015 | - | $0.00(0.0%) | $900.00(-10.0%) |
Oct 2014 | - | $0.00(-100.0%) | $1000.00(-9.1%) |
Jul 2014 | $1100.00(+175.0%) | $800.00(+700.0%) | $1100.00(+175.0%) |
Apr 2014 | - | $100.00(0.0%) | $400.00(0.0%) |
Jan 2014 | - | $100.00(0.0%) | $400.00(0.0%) |
Oct 2013 | - | $100.00(0.0%) | $400.00(0.0%) |
Jul 2013 | $400.00(-76.5%) | $100.00(0.0%) | $400.00(-42.9%) |
Apr 2013 | - | $100.00(0.0%) | $700.00(-36.4%) |
Jan 2013 | - | $100.00(0.0%) | $1100.00(-21.4%) |
Oct 2012 | - | $100.00(-75.0%) | $1400.00(-17.6%) |
Jul 2012 | $1700.00(-32.0%) | $400.00(-20.0%) | $1700.00(-10.5%) |
Apr 2012 | - | $500.00(+25.0%) | $1900.00(-9.5%) |
Jan 2012 | - | $400.00(0.0%) | $2100.00(-8.7%) |
Oct 2011 | - | $400.00(-33.3%) | $2300.00(-8.0%) |
Jul 2011 | $2500.00(+92.3%) | $600.00(-14.3%) | $2500.00(-7.4%) |
Apr 2011 | - | $700.00(+16.7%) | $2700.00(+22.7%) |
Jan 2011 | - | $600.00(0.0%) | $2200.00(+22.2%) |
Oct 2010 | - | $600.00(-25.0%) | $1800.00(+28.6%) |
Jul 2010 | $1300.00(+550.0%) | $800.00(+300.0%) | $1400.00(+75.0%) |
Apr 2010 | - | $200.00(0.0%) | $800.00(+33.3%) |
Jan 2010 | - | $200.00(0.0%) | $600.00(+50.0%) |
Oct 2009 | - | $200.00(0.0%) | $400.00(+100.0%) |
Jul 2009 | $200.00 | $200.00(>+9900.0%) | $200.00(>+9900.0%) |
Apr 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Jan 2009 | - | $0.00 | $0.00 |
FAQ
- What is BriaCell Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual D&A year-on-year change?
- What is BriaCell Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly D&A year-on-year change?
- What is BriaCell Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for BriaCell Therapeutics?
- What is BriaCell Therapeutics TTM D&A year-on-year change?
What is BriaCell Therapeutics annual depreciation & amortization?
The current annual D&A of BCTX is $83.90 K
What is the all time high annual D&A for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual depreciation & amortization is $83.90 K
What is BriaCell Therapeutics annual D&A year-on-year change?
Over the past year, BCTX annual depreciation & amortization has changed by +$68.60 K (+448.37%)
What is BriaCell Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of BCTX is $26.70 K
What is the all time high quarterly D&A for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly depreciation & amortization is $72.40 K
What is BriaCell Therapeutics quarterly D&A year-on-year change?
Over the past year, BCTX quarterly depreciation & amortization has changed by +$22.90 K (+602.63%)
What is BriaCell Therapeutics TTM depreciation & amortization?
The current TTM D&A of BCTX is $106.70 K
What is the all time high TTM D&A for BriaCell Therapeutics?
BriaCell Therapeutics all-time high TTM depreciation & amortization is $106.70 K
What is BriaCell Therapeutics TTM D&A year-on-year change?
Over the past year, BCTX TTM depreciation & amortization has changed by +$91.50 K (+601.97%)